Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-12 to 2024-03-13
Current total value of award: $252.6
Description: 4563937595!LORAZEPAM 2 MG/ML VIALML